Literature DB >> 27601018

Modifiable risk factors for gestational diabetes recurrence.

Naama Schwartz1,2, Manfred S Green3, Enav Yefet4, Zohar Nachum4,5.   

Abstract

The literature on risk factors for gestational diabetes mellitus recurrence is inconsistent and sometimes contradictory. The importance of inter-pregnancy interval and parity, remains unclear. We aimed to explore controversial risk factors for gestational diabetes mellitus recurrence, especially the modifiable ones, and to develop a prediction model in a cohort of women with gestational diabetes mellitus. A retrospective, population-based, cross-sectional cohort study was performed. The study included 788 women with gestational diabetes mellitus that delivered between 1991-2012 and had consecutive deliveries at a university affiliated hospital in Israel. Women with pre-existing diabetes were excluded. Factors associated with gestational diabetes mellitus recurrence were examined using log-binomial models to estimate prevalence ratios with 95 % confidence intervals. Multivariate analysis revealed that both inter-pregnancy interval and multiparity were significant risk factors for gestational diabetes mellitus recurrence. Other significant risk factors were maternal age, gestational diabetes mellitus diagnosis week, oral glucose tolerance test values, body mass index gain between pregnancies and insulin use; the latter and multiparity had the strongest effect size (PR ≥ 1.2). Among multiparous women, the association between inter-pregnancy interval and gestational diabetes mellitus recurrence was significantly lower (P = 0.0004) compared with primiparous women (PR = 1.11 [95 % CI 1.09-1.13] versus PR = 1.17 [95 % CI 1.15-1.20], respectively). The model we developed, predicts that reducing the inter-pregnancy interval and weight gain between pregnancies can reduce substantially the risk of gestational diabetes mellitus recurrence. The results suggest that weight gain and inter-pregnancy interval are modifiable risk factors for gestational diabetes mellitus recurrence. Our model could assist physicians in advising women with gestational diabetes mellitus in reducing the risk of recurrent gestational diabetes mellitus during subsequent pregnancies.

Entities:  

Keywords:  Gestational diabetes; Recurrence; Risk factors

Mesh:

Year:  2016        PMID: 27601018     DOI: 10.1007/s12020-016-1087-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  28 in total

Review 1.  Recurrence of gestational diabetes mellitus: a systematic review.

Authors:  Catherine Kim; Diana K Berger; Shadi Chamany
Journal:  Diabetes Care       Date:  2007-02-08       Impact factor: 19.112

Review 2.  Epidemiologic approaches for studying recurrent pregnancy outcomes: challenges and implications for research.

Authors:  Cande V Ananth
Journal:  Semin Perinatol       Date:  2007-06       Impact factor: 3.300

3.  Change in body mass index between pregnancies and the risk of gestational diabetes in a second pregnancy.

Authors:  Samantha F Ehrlich; Monique M Hedderson; Juanran Feng; Erica R Davenport; Erica P Gunderson; Assiamira Ferrara
Journal:  Obstet Gynecol       Date:  2011-06       Impact factor: 7.661

4.  Gestational diabetes: risk of recurrence in subsequent pregnancies.

Authors:  Darios Getahun; Michael J Fassett; Steven J Jacobsen
Journal:  Am J Obstet Gynecol       Date:  2010-07-13       Impact factor: 8.661

5.  Recurrence of gestational diabetes: who is at risk?

Authors:  C A Major; M deVeciana; J Weeks; M A Morgan
Journal:  Am J Obstet Gynecol       Date:  1998-10       Impact factor: 8.661

6.  The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy.

Authors:  O Langer; L Brustman; A Anyaegbunam; R Mazze
Journal:  Am J Obstet Gynecol       Date:  1987-09       Impact factor: 8.661

Review 7.  Recurrent gestational diabetes: risk factors, diagnosis, management, and implications.

Authors:  Joseph N Bottalico
Journal:  Semin Perinatol       Date:  2007-06       Impact factor: 3.300

8.  Prediction of diabetes recurrence in women with class A1 (diet-treated) gestational diabetes.

Authors:  Heather J Holmes; Julie Y Lo; Donald D McIntire; Brian M Casey
Journal:  Am J Perinatol       Date:  2009-10-05       Impact factor: 1.862

9.  Risk factors of gestational diabetes mellitus recurrence: a meta-analysis.

Authors:  Naama Schwartz; Zohar Nachum; Manfred S Green
Journal:  Endocrine       Date:  2016-03-21       Impact factor: 3.633

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  7 in total

1.  Pregnancy in human IAPP transgenic mice recapitulates beta cell stress in type 2 diabetes.

Authors:  Tatyana Gurlo; Sarah Kim; Alexandra E Butler; Chang Liu; Lina Pei; Madeline Rosenberger; Peter C Butler
Journal:  Diabetologia       Date:  2019-03-09       Impact factor: 10.122

2.  Trends in Gestational Diabetes at First Live Birth by Race and Ethnicity in the US, 2011-2019.

Authors:  Nilay S Shah; Michael C Wang; Priya M Freaney; Amanda M Perak; Mercedes R Carnethon; Namratha R Kandula; Erica P Gunderson; Kai McKeever Bullard; William A Grobman; Matthew J O'Brien; Sadiya S Khan
Journal:  JAMA       Date:  2021-08-17       Impact factor: 157.335

3.  Myoinositol supplementation in the treatment of gestational diabetes mellitus: effects on glycaemic control and maternal-foetal outcomes.

Authors:  Valentina Guarnotta; Gianluca Cuva; Maria Pia Imbergamo; Carla Giordano
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-26       Impact factor: 3.105

4.  Postprandial glycemic control during gestational diabetes pregnancy predicts the risk of recurrence.

Authors:  Naama Schwartz; Manfred S Green; Enav Yefet; Zohar Nachum
Journal:  Sci Rep       Date:  2018-04-20       Impact factor: 4.379

Review 5.  Myoinositol in the Prevention of Gestational Diabetes Mellitus: Is It Sensible?

Authors:  Angelika Sobota-Grzeszyk; Mariusz Kuźmicki; Jacek Szamatowicz
Journal:  J Diabetes Res       Date:  2019-12-07       Impact factor: 4.011

6.  ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus.

Authors:  Shakila Thangaratinam; Shamil D Cooray; Nithya Sukumar; Mohammed S B Huda; Roland Devlieger; Katrien Benhalima; Fionnuala McAuliffe; Ponnusamy Saravanan; Helena J Teede
Journal:  Eur J Endocrinol       Date:  2020-08       Impact factor: 6.558

7.  Angiogenic Imbalance and Inflammatory Biomarkers in the Prediction of Hypertension as Well as Obstetric and Perinatal Complications in Women with Gestational Diabetes Mellitus.

Authors:  Almudena Lara-Barea; Begoña Sánchez-Lechuga; Antonio Campos-Caro; Juan Antonio Córdoba-Doña; Raquel de la Varga-Martínez; Ana I Arroba; Fernando Bugatto; Manuel Aguilar-Diosdado; Cristina López-Tinoco
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.